Teva, Glenmark to pay $255 million to resolve DOJ price-fixing claims
Washington, D.C. (August 29, 2023) -- Teva Pharmaceuticals and Glenmark Pharmaceuticals reached deferred prosecution agreements with the Department of Justice to resolve antitrust claims over a generic drug price-fixing cartel....